2-(4-Fluorophenyl)-2-[4-(2-methylphenyl)piperazin-1-yl]acetic acid, 250mg

N,N'-Methanediylidenebis(2,6-diisopropylaniline), 95.0%, 10g

N-(4-Hydroxyphenyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 97%, 5g

(4-Amino-2-fluorophenyl)methanol, 95+%, 250mg

3-AMINO-1-(TRIFLUOROMETHYL)CYCLOBUTAN-1-OL HCL, 95.0%, 250mg

Phenyl(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanone, 97%, 5g

6-Methoxy-2-naphthaleneboronic acid, 96.0%, 5g

2-(6-METHOXYPYRIDIN-3-YL)ACETONITRILE, 95.0%, 1g

3-(5-Chloro-[1,2,4]thiadiazol-3-yl)-pyridine, 95.0%, 100mg

Fmoc-3-Nitro-tyrosine, >99%, 10g

Cuba de muestra ROTILABO® con cierre de rosca, 90 ml, 5 Unidad(es)

(3S,5R)-5-(hydroxymethyl)pyrrolidin-3-ol hydrochloride, 97.0%, 25g

2-Bromo-7-(methoxymethoxy)naphthalene, 98%, 250mg